Briggs W. Morrison, M.D., who was born on June 1, 1968, has built a solid career in the medical field, holding an M.D. and a Ph.D. from the University of Pennsylvania. He led Syndax Pharmaceuticals as CEO for several years...
Briggs W. Morrison, M.D., who was born on June 1, 1968, has built a solid career in the medical field, holding an M.D. and a Ph.D. from the University of Pennsylvania. He led Syndax Pharmaceuticals as CEO for several years until he transitioned to President and Head of Research and Development in early 2022. His experience in the pharmaceutical industry has shaped his leadership style, focusing on innovative drug development. Dr. Morrison has a well-defined compensation strategy that relates strongly to company performance, with a notable peak total pay of over $2 million in 2020. His commitment to the company is evident, as he recently agreed to serve as an advisor after stepping down from his CEO role. Key performance metrics that drive his compensation include revenue growth and operational success. This approach resonates with his goal of long-term value creation. Dr. Morrison’s leadership reflects his deep knowledge in medicine and a strategic vision for advancing pharmaceutical research.